Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effect of Clarithromycin on the Pharmacokinetics of Cabergoline in Healthy Controls and in Patients With Parkinson’s Disease

Published:2006 Issue:1 Volume:100 Page:59-64
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Nakatsuka Akiko,Nagai Masahiro,Yabe Hayato,Nishikawa Noriko,Nomura Takuo,Moritoyo Hiroyoko,Moritoyo Takashi,Nomoto Masahiro

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference27 articles.

1. Evidence-based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004

2. 2 Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson’s disease: treatment guidelines. American Academy of Neurology. Neurology.1998;50 (3 Suppl 3):S1–S57.

3. Early Treatment of Parkinson??s Disease with Cabergoline Delays the Onset of Motor Complications

4. 4 Deleu D, Northway MG, Hanssens Y. Clinical pharmacokinetic and pharmacodynamic properties of drugs used in the treatment of Parkinson’s disease. Clin Pharmacokinet. 2002;41:261–309.

5. Effects of Acute or Prolonged Administration of Cabergoline on Parkinsonism Induced by MPTP in Common Marmosets

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A validated LC–MS/MS method for analysis of Cabergoline in human plasma with its implementation in a bioequivalent study: investigation of method greenness;BMC Chemistry;2022-09-24

2. Cabergoline: a review of its use in the inhibition of lactation for women living with HIV;Journal of the International AIDS Society;2019-06

3. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients;Journal of Antimicrobial Chemotherapy;2019-05-24

4. Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects;Current Treatment Options in Gastroenterology;2018-10-25

5. Arzneimitteltherapiesicherheit: Das Interaktionspotenzial der Dopaminagonisten;Deutsches Ärzteblatt Online;2017-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3